<br />
DERMATOLOGY<br />
EMJ Dermatol. 2019 Suppl 5 • europeanmedical-journal.com<br />
INSIDE<br />
IL-23 Inhibition as a Key Component in<br />
Psoriasis Treatment is Here to Stay<br />
IL-23 Inhibition as a Key Component in<br />
Psoriasis Treatment is Here to Stay<br />
This satellite symposium took place on April 25th 2019 as part<br />
of the 6th Congress of the Skin Inflammation & Psoriasis<br />
International Network (SPIN) in Paris, France<br />
Chairpeople: Andreas Pinter1<br />
Speakers: Elke de Jong,2 Andreas Pinter1<br />
1. University Hospital Frankfurt am Main, Frankfurt am Main, Germany<br />
2. Radboud University Medical Center (Radboudumc), Nijmegen, the Netherlands<br />
Disclosure: Prof de Jong has received research grants for the independent research fund of the<br />
Department of Dermatology, Radboudumc, Nijmegen, the Netherland<a title="EMJ Dermatol. 2019 Suppl 5 page 1" href="http://viewer.zmags.com/publication/f529bdab?page=1"> DERMATOLOGY EMJ Dermatol. 2019 Suppl 5 • european</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 2" href="http://viewer.zmags.com/publication/f529bdab?page=2"> IL-23 Inhibition as a Key Component in Psorias</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 3" href="http://viewer.zmags.com/publication/f529bdab?page=3"> He explored VOYAGE 1 data that showed that the IL</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 4" href="http://viewer.zmags.com/publication/f529bdab?page=4"> show switching between biologics is safe and effe</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 5" href="http://viewer.zmags.com/publication/f529bdab?page=5"> treated, with updosing effective in some patients</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 6" href="http://viewer.zmags.com/publication/f529bdab?page=6"> In the reSURFACE 1 trial data for tildrakizumab (</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 7" href="http://viewer.zmags.com/publication/f529bdab?page=7"> improvements in scalp scores versus 69.2% re</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 8" href="http://viewer.zmags.com/publication/f529bdab?page=8"> age, sex, and comorbidities from registries to in</a>
<a title="EMJ Dermatol. 2019 Suppl 5 page 9" href="http://viewer.zmags.com/publication/f529bdab?page=9"> VOYAGE 1 trial. J Am Acad Dermatol. 31. 2017</a>